» Articles » PMID: 31967503

Practical Guide to Evaluating Myocardial Disease by Cardiac MRI

Overview
Specialties Oncology
Radiology
Date 2020 Jan 23
PMID 31967503
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

A spectrum of pathophysiologic mechanisms can lead to the development of myocardial disorders including ischemia, genetic abnormalities, and systemic disorders. Cardiac MRI identifies different myocardial disorders, provides prognostic information, and directs therapy. In comparison with other imaging modalities, cardiac MRI has the advantage of allowing both functional assessment and tissues characterization in a single examination without the use of ionizing radiation. Newer cardiac MRI techniques including mapping can provide additional information about myocardial disease that may not be detected using conventional techniques. Emerging techniques including MR spectroscopy and finger printing will likely change the way we understand the pathophysiology mechanisms of the wide array of myocardial disorders. Imaging of myocardial disorders encompasses a large variety of conditions including both ischemic and nonischemic diseases. Cardiac MRI sequences, such as balanced steady-state free precession and late gadolinium enhancement, play a critical role in establishing diagnosis, determining prognosis, and guiding therapeutic management. Additional sequences-including perfusion imaging, T2*, real-time cine, and T2-weighted sequences-should be performed in specific clinical scenarios. There is emerging evidence for the use of mapping in imaging of myocardial disease. Multiple other new techniques are currently being studied. These novel techniques will likely change the way myocardial disorders are understood and diagnosed in the near future.

Citing Articles

A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies.

Netala V, Teertam S, Li H, Zhang Z Cells. 2024; 13(17.

PMID: 39273041 PMC: 11394358. DOI: 10.3390/cells13171471.


Evaluation of myocardial strain using cardiovascular magnetic resonance imaging in patients with β-thalassemia major.

Ko S J Cardiovasc Imaging. 2024; 32(1):26.

PMID: 39252137 PMC: 11384706. DOI: 10.1186/s44348-024-00033-2.


Automated assessment of cardiac pathologies on cardiac MRI using T1-mapping and late gadolinium phase sensitive inversion recovery sequences with deep learning.

Paciorek A, von Schacky C, Foreman S, Gassert F, Gassert F, Kirschke J BMC Med Imaging. 2024; 24(1):43.

PMID: 38350900 PMC: 10865672. DOI: 10.1186/s12880-024-01217-4.


Artificial Intelligence Applications in Cardiovascular Magnetic Resonance Imaging: Are We on the Path to Avoiding the Administration of Contrast Media?.

Cau R, Pisu F, Suri J, Mannelli L, Scaglione M, Masala S Diagnostics (Basel). 2023; 13(12).

PMID: 37370956 PMC: 10297403. DOI: 10.3390/diagnostics13122061.


Experience of 500 cardiovascular magnetic resonance imaging and systematic analysis of cases.

Ozkok S, Yucel I, Sasmazel A, Celebi A North Clin Istanb. 2023; 10(1):108-121.

PMID: 36910429 PMC: 9996649. DOI: 10.14744/nci.2022.28445.